PET/CT in the Evaluation of Childhood Sarcomas
- 1 April 2005
- journal article
- review article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 184 (4), 1293-1304
- https://doi.org/10.2214/ajr.184.4.01841293
Abstract
OBJECTIVE. Our objective was to review our preliminary experience with PET/CT in evaluating childhood sarcomas including rhabdomyosarcoma (n = 28), the Ewing's sarcoma family of tumors (n = 14), nonrhabdomyosarcoma soft-tissue sarcoma (n = 9), osteosarcoma (n = 8), chondrosarcoma (n = 1), and embryonal sarcoma (n = 1).CONCLUSION. We found PET/CT useful in depicting an unknown primary rhabdomyosarcoma and detecting unsuspected and unusual metastatic sites of childhood sarcomas. It was useful in monitoring response to chemotherapy, radiation therapy, and radiofrequency ablation and aided the postoperative evaluation of tumor resection sites.Keywords
This publication has 6 references indexed in Scilit:
- Clinical Applications of PET in OncologyRadiology, 2004
- Diagnostic strategies for unknown primary cancerCancer, 2004
- Clinical Role of FDG PET in Evaluation of Cancer PatientsRadioGraphics, 2003
- Value of FDG Positron Emission Tomography in Conjunction with MR Imaging for Evaluating Therapy Response in Patients with Musculoskeletal SarcomasAmerican Journal of Roentgenology, 2002
- Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomographyCancer, 2002
- Rhabdomyosarcoma, presenting as disseminated malignancy from an unknown primary site: A retrospective study of ten pediatric casesMedical and Pediatric Oncology, 1989